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Introduction
A need for evidence-based guidelines for the management
of paediatric rheumatic diseases (PRD) has been recog-
nised. In 2012 the European Agency for Health and
Consumers signed the contract for a new European initia-
tive SHARE: Single Hub and Access point for paediatric
Rheumatology in Europe (project number 2011 1202).
Objectives
Workpackage 4 (WP4) aimed to identify current access to
paediatric rheumatology services and practice in European
countries in their complexity. Non-European countries
from the PRINTO network were included in order to
allow comparisons.
Methods
The survey questionnaires were developed through con-
sensus meetings of the SHARE consortium partners and
consultations with experts from across PReS Working
Groups. The Surveys have been stratified into 4 levels:
Country-wide, Centre-specific, Disease-specific and Perso-
nal. Final survey texts were transformed into electronic
web-based system hosted by PRINTO and presented to
paediatric rheumatology community via PRINTO mailing
list. Results of the country survey are presented here.
Results
The country survey was completed by representatives
of 22 European countries (14 Western and 8 Eastern/
Central) and 11 other countries. Results were grouped
into 3 specific topics: 1.The healthcare system (provi-
ders), organisation of paediatric rheumatology (PR)
care, access to care. 2.Evidence based and qualified care.
3.Education and employment issues. In majority of Eur-
opean countries health professionals in PR care form an
official working group or national society. Proportion of
PR patients treated by general paediatricians or adult
rheumatologists is low across Europe (mostly <25%).
Proportion of patients treated in tertiary centres of
university hospitals is higher in Eastern European coun-
tries. In Western Europe the similar proportion of
patients are treated in paediatric departments of other
than tertiary hospitals. National guidelines/recommen-
dations are more frequently available in Western than
Eastern European countries (64 vs 25%). While licenced
biologics are available in all Western countries, this is
not the case for Eastern Europe. Moreover, treatment
limitations are more prominent in Eastern countries.
Official recognition of paediatric rheumatology as a
subspecialty varies. It is generally lower in Europe in
comparison to non-European countries and reaches 37
(Eastern Europe) to 57% (Western Europe). Defined
training scheme is available in over 60% of Western
countries but only in 37% of Eastern ones. Availability
of educational resources has been good for over 70% of
all European countries. The similar responses between
Eastern and Western Europe were also related to the
availability of PR pre-graduate teaching. Only 35% of
Western European countries employ a system of post-
graduate/continuing education while such a system
works in nearly 90% of Eastern European countries.
Over 70% of all respondents have confirmed the need
for more paediatric rheumatologists in their countries
within the next 5 years.
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Conclusion
Through the WP4 of the SHARE project important
information has been collected forming a thorough
inventory of paediatric rheumatology practice in indivi-
dual European countries. This will serve as a baseline
for the formulation of internationally achievable best
practices in PRD management. These practices will be
presented to stakeholders such as individual paediatric
rheumatology units, health authorities, health insurance
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